- Email: [email protected]
6 (2013) 888–893]
Clinical Nutrition 34 (2015) 167
Contents lists available at ScienceDirect
Clinical Nutrition journal homepage: http://www.elsevier.com/locate/clnu
Corrigendum
Corrigendum to “Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): A systematic review” [Clin Nutr 32/6 (2013) 888e893] Janet M. Schloss a, Maree Colosimo a, b, Caroline Airey c, Paul P. Masci a, Anthony W. Linnane a, Luis Vitetta a, * a
The University of Queensland, School of Medicine, Centre for Integrative Clinical and Molecular Medicine, Level 5, TRI, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane 4102, Australia Medical Oncology Group of Australia, Clinical Oncology Society of Australia, Queensland Clinical Oncology Group, Brisbane 4000, Australia c Neurology Fellow at Queensland Health, Department of Neurology, Ned Hanlon Building, RBWH, Herston, Brisbane 4006, Australia b
The authors regret that the caption for Figure 1 should have cited reference 6 (Park SB et al. Mechanisms underlying chemotherapyinduced neurotoxicity and the potential for neuroprotective strategies. Curr Med Chem 2008; 15:3081e94) as the source of the figure, rather than reference 7. The image is reproduced from reference 6 with permission. The authors would like to apologise for any inconvenience caused.
DOI of original article: http://dx.doi.org/10.1016/j.clnu.2013.04.007. * Corresponding author. The Centre for Integrative Clinical and Molecular Medicine, The University of Queensland, School of Medicine, Level 5, TRI, Princess, Alexandra Hospital, Ipswich Road, Woolloongabba, Queensland 4102, Australia. Tel.: þ61 731762903. E-mail address: [email protected] (L. Vitetta). http://dx.doi.org/10.1016/j.clnu.2014.09.003 0261-5614/© 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Contents lists available at ScienceDirect
Clinical Nutrition journal homepage: http://www.elsevier.com/locate/clnu
Corrigendum
Corrigendum to “Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): A systematic review” [Clin Nutr 32/6 (2013) 888e893] Janet M. Schloss a, Maree Colosimo a, b, Caroline Airey c, Paul P. Masci a, Anthony W. Linnane a, Luis Vitetta a, * a
The University of Queensland, School of Medicine, Centre for Integrative Clinical and Molecular Medicine, Level 5, TRI, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane 4102, Australia Medical Oncology Group of Australia, Clinical Oncology Society of Australia, Queensland Clinical Oncology Group, Brisbane 4000, Australia c Neurology Fellow at Queensland Health, Department of Neurology, Ned Hanlon Building, RBWH, Herston, Brisbane 4006, Australia b
The authors regret that the caption for Figure 1 should have cited reference 6 (Park SB et al. Mechanisms underlying chemotherapyinduced neurotoxicity and the potential for neuroprotective strategies. Curr Med Chem 2008; 15:3081e94) as the source of the figure, rather than reference 7. The image is reproduced from reference 6 with permission. The authors would like to apologise for any inconvenience caused.
DOI of original article: http://dx.doi.org/10.1016/j.clnu.2013.04.007. * Corresponding author. The Centre for Integrative Clinical and Molecular Medicine, The University of Queensland, School of Medicine, Level 5, TRI, Princess, Alexandra Hospital, Ipswich Road, Woolloongabba, Queensland 4102, Australia. Tel.: þ61 731762903. E-mail address: [email protected] (L. Vitetta). http://dx.doi.org/10.1016/j.clnu.2014.09.003 0261-5614/© 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.